SCHEMBL3843553

SCHEMBL3843553

O=C(O)NCCc1cc(Br)c[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.43
ERCC4 Q92889 1/20 0.43
MTNR1A P48039 2/20 0.41
MTNR1B P49286 2/20 0.41
KDM4E B2RXH2 7/20 0.39
HSD17B10 Q99714 7/20 0.39
ALDH1A1 P00352 6/20 0.39
CYP1A2 P05177 1/20 0.39
PKM P14618 1/20 0.38
HPGD P15428 5/20 0.37
TSHR P16473 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
LTA4H P09960 1/20 0.37
PLA2G2A P14555 1/20 0.37
USP2 O75604 1/20 0.36
MAPT P10636 1/20 0.36
DAO P14920 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3844306 0.79 IDO1 (0.48) MTNR1AMTNR1BKDM4EHSD17B10ALDH1A1
SCHEMBL3844258 0.75 ERCC1 (0.50) ERCC1ERCC4KDM4EALDH1A1PKM
SCHEMBL25420774 0.73 EPHX2 (0.51) ERCC1ERCC4ALDH1A1PKMHPGD
SCHEMBL15816176 0.72 ERCC1 (0.55) ERCC1ERCC4KDM4EALDH1A1PKM
SCHEMBL3841574 0.72 ALDH1A1 (0.43) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL11080741 0.71 MTNR1A (0.78) MTNR1AMTNR1BKDM4EALDH1A1CYP1A2
SCHEMBL17546137 0.70 ERCC1 (0.52) ERCC1ERCC4ALDH1A1PKMHPGD
SCHEMBL13729262 0.70 CREBBP (0.47) ERCC1ERCC4PKMKMT2AMEN1
SCHEMBL1157319 0.69 NPC1 (0.38) MTNR1AMTNR1BALDH1A1PKMHPGD
SCHEMBL2635629 0.68 DAO (0.43) ERCC1ERCC4PKMDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114898-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS Amgen Inc. (US) 2009-11-11 EP disclosed
WO-2008103277-A2 NITROGEN-CONTAINING HETEROCYCLYL KETONES AND THEIR USE AS C-MET INHIBITORS AMGEN INC. (US) 2008-08-28 WO disclosed